Caroline F. Thorn, Ph.D. 2-11-2011 submission id: PS216282
CL:0000182
fac
bad
aef
a07
a0d
a07
a0d
a07
a07
c5e
a07
a07
e04
a07
ee1
ac0
a7a
e90
eda
e2c
c46
a07
eb8
ab3
f3d
f04
f04
f3d
ab3
a07
a07
a07
b4d
ab3
f3d
ab3
b4d
aef
bad
fac
f3d
f04
f3d
f04
d86
d86
a07
eb8
efflux of the active metabolite
e3c
18088268
PubMed
Drug resistance in epilepsy: more twists in the tale.
Epilepsia
2007
Sisodiya SM
Goldstein DB
17495417
PubMed
Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphine.
Drug Metab Pharmacokinet
2007
Hara Y
Nakajima M
Miyamoto K
Yokoi T
20080116
PubMed
Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy.
Neuropharmacology
2010
Luna-Tort??s C
Fedrowitz M
L??scher W
15292462
PubMed
N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7.
J Pharmacol Exp Ther
2004
Staines AG
Coughtrie MW
Burchell B
15915352
PubMed
Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects.
Eur J Clin Pharmacol
2005
Kim KA
Oh SO
Park PW
Park JY
18463198
PubMed
Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.
Drug Metab Dispos
2008
Pearce RE
Lu W
Wang Y
Uetrecht JP
Correia MA
Leeder JS
17112801
PubMed
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine.
Clin Pharmacol Ther
2006
Oscarson M
Zanger UM
Rifki OF
Klein K
Eichelbaum M
Meyer UA
16135660
PubMed
Pathways of carbamazepine bioactivation in vitro: II. The role of human cytochrome P450 enzymes in the formation of 2-hydroxyiminostilbene.
Drug Metab Dispos
2005
Pearce RE
Uetrecht JP
Leeder JS
18824002
PubMed
Several major antiepileptic drugs are substrates for human P-glycoprotein.
Neuropharmacology
2008
Luna-Tort??s C
Fedrowitz M
L??scher W
12386121
PubMed
Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites.
Drug Metab Dispos
2002
Pearce RE
Vakkalagadda GR
Leeder JS
3319544
PubMed
Clinically significant carbamazepine drug interactions: an overview.
Epilepsia
1987
Pippenger CE
16188027
PubMed
RLIP76, a non-ABC transporter, and drug resistance in epilepsy.
BMC Neurosci
2005
Awasthi S
Hallene KL
Fazio V
Singhal SS
Cucullo L
Awasthi YC
Dini G
Janigro D
19702527
PubMed
Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6.
Curr Drug Metab
2009
Mo SL
Liu YH
Duan W
Wei MQ
Kanwar JR
Zhou SF
11318771
PubMed
Carbamazepine is not a substrate for P-glycoprotein.
Br J Clin Pharmacol
2001
Owen A
Pirmohamed M
Tettey JN
Morgan P
Chadwick D
Park BK
18463199
PubMed
Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin.
Drug Metab Dispos
2008
Lu W
Uetrecht JP
18096676
PubMed
CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.
Drug Metab Dispos
2008
Kang P
Liao M
Wester MR
Leeder JS
Pearce RE
Correia MA
15692831
PubMed
Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.
Eur J Clin Pharmacol
2005
Nakajima Y
Saito Y
Shiseki K
Fukushima-Uesaka H
Hasegawa R
Ozawa S
Sugai K
Katoh M
Saitoh O
Ohnuma T
Kawai M
Ohtsuki T
Suzuki C
Minami N
Kimura H
Goto Y
Kamatani N
Kaniwa N
Sawada J
19255940
PubMed
Functional characterization of CYP3A4.16: catalytic activities toward midazolam and carbamazepine.
Xenobiotica
2009
Maekawa K
Yoshimura T
Saito Y
Fujimura Y
Aohara F
Emoto C
Iwasaki K
Hanioka N
Narimatsu S
Niwa T
Sawada J
18086001
PubMed
The association between polymorphisms in RLIP76 and drug response in epilepsy.
Pharmacogenomics
2007
Leschziner GD
Jorgensen AL
Andrew T
Williamson PR
Marson AG
Coffey AJ
Middleditch C
Balding DJ
Rogers J
Bentley DR
Chadwick D
Johnson MR
Pirmohamed M
10668858
PubMed
Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.
Clin Pharmacokinet
2000
Dresser GK
Spence JD
Bailey DG
21692796
PubMed
In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.
Epilepsia
2011
Zhang C
Zuo Z
Kwan P
Baum L
17437410
PubMed
Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
Epilepsia
2007
Soranzo N
Kelly L
Martinian L
Burley MW
Thom M
Sali A
Kroetz DL
Goldstein DB
Sisodiya SM
19450124
PubMed
Gene-wide tagging study of association between ABCB1 polymorphisms and multidrug resistance in epilepsy in Han Chinese.
Pharmacogenomics
2009
Kwan P
Wong V
Ng PW
Lui CH
Sin NC
Poon WS
Ng HK
Wong KS
Baum L
19415824
PubMed
Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
Pharmacogenet Genomics
2009
Ufer M
Mosyagin I
Muhle H
Jacobsen T
Haenisch S
H??sler R
Faltraco F
Remmler C
von Spiczak S
Kroemer HK
Runge U
Boor R
Stephani U
Cascorbi I
20216337
PubMed
A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy.
Pharmacogenet Genomics
2010
Kim WJ
Lee JH
Yi J
Cho YJ
Heo K
Lee SH
Kim SW
Kim MK
Kim KH
In Lee B
Lee MG